Publication Name	World Journal of Transplantation
Manuscript ID	63581
Country	United Kingdom

Received	2021-01-29 16:51
Peer-Review Started	2021-01-29 17:00
To Make the First Decision
Return for Revision	2021-04-06 17:08
Revised	2021-04-10 18:25
Second Decision	2021-08-19 03:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-19 06:49
Articles in Press	2021-08-19 06:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-13 04:33
Publish the Manuscript Online	2021-09-15 06:29

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Journey of a patient with scleroderma from renal failure up to kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Fedaey Abbas, Mohsen El Kossi, Ihab Sakr Shaheen, Ajay Sharma and Ahmed Halawa
Funding Agency and Grant Number
Corresponding Author	Ahmed Halawa, FRCS, MD, Senior Lecturer, Surgeon, Department of Transplant Surgery, Sheffield Teaching Hospital, Herries Road, Sheffield S5 7AU, United Kingdom. ahmed.halawa@sth.nhs.uk
Key Words	Systemic sclerosis; Scleroderma renal crisis; Risk factors; Renal failure; Hemodialysis; Kidney transplant
Core Tip	The current progress in the management of systemic sclerosis has its impact on improving patient’s survival and quality of life. Patients developed scleroderma renal crisis have greatly managed after commencing angiotensin converting enzyme inhibitors. Moreover, scleroderma patient with kidney failure has a marvelous therapeutic option receiving a kidney transplant with a greatly improved extrarenal manifestations. However, patients with end stage kidney failure, maintained on regular dialysis, should have enough period permitting renal recovery before attempting the transplant procedures. This duration may be actually extended up to two years. Patients with scleroderma may show the highest rate of renal recovery among dialysis patients.
Publish Date	2021-09-15 06:29
Citation	Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Journey of a patient with scleroderma from renal failure up to kidney transplantation. World J Transplant 2021; 11(9): 372-387
URL	https://www.wjgnet.com/2220-3230/full/v11/i9/372.htm
DOI	https://dx.doi.org/10.5500/wjt.v11.i9.372

Full Article (PDF)	WJT-11-372.pdf
Full Article (Word)	WJT-11-372.docx
Manuscript File	63581_Auto_Edited-JLW.docx
Answering Reviewers	63581-Answering reviewers.pdf
Audio Core Tip	63581-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	63581-Conflict-of-interest statement.pdf
Copyright License Agreement	63581-Copyright license agreement.pdf
Peer-review Report	63581-Peer-review(s).pdf
Scientific Misconduct Check	63581-Scientific misconduct check.pdf
Scientific Editor Work List	63581-Scientific editor work list.pdf